Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-16
1999-08-03
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, A61K 31505, A61K 3155
Patent
active
059325852
ABSTRACT:
The invention is a method of treating or inhibiting neutropenia, or accelerating neutrophil recovery in a mammal in need thereof, which comprises administering to said mammal an effective amount of a compound having the formula: ##STR1## wherein R.sub.1 and R.sub.2 are each, independently selected from the group consisting of hydrogen, alkyl of 1-6 carbon atoms, optionally substituted benzoyl, ##STR2## or R.sub.1 and R.sub.2 are methylene groups which are taken together to form a 4-7 membered saturated heterocyclic ring;
REFERENCES:
patent: 4713383 (1987-12-01), Francis et al.
patent: 4916137 (1990-04-01), Epstein et al.
Epstein Joseph W.
Gibbons James J.
Levin Jeremy I.
Lucas Judy
American Cyanamid Company
Jordan Kimberly
Milowsky Arnold S.
LandOfFree
Method of treating or inhibiting neutropenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or inhibiting neutropenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or inhibiting neutropenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849730